LumiraDx test strips SARS-CoV-2 & Flu A/B

The LumiraDx Test Strip SARS-CoV-2 & Flu A/B is a rapid microfluidic immunofluorescence test designed to optimize patient flow and accelerate clinical workflow. In combination with the LumiraDx Platform, this test provides accurate and actionable results comparable to laboratory values in just 12 minutes. This is particularly helpful for the rapid diagnosis of patients with suspected influenza and/or COVID-19. The test allows three diseases to be tested simultaneously - Flu A, Flu B and COVID-19 - all from a single nasal swab sample. This efficiency facilitates fast and targeted medical care and reduces the workload for medical staff.

The accuracy of the test is remarkable: the test shows a PPA (positive predictive agreement) of up to 95.5% for SARS-CoV-2 Ag and a NPA (negative predictive agreement) of up to 99.0%. For Flu A, the PPA is 83.3 % and the NPA is 97.6 %, while the test for Flu B offers a PPA of 80 % and an NPA of 94.9 %. This ensures that the test results are reliable and provide a sound basis for clinical decision making.

Another advantage of the LumiraDx test strip is its versatility: the prepared sample can also be used with the LumiraDx SARS-CoV-2 & RSV test, which increases the flexibility of the test and simplifies its use in various diagnostic scenarios. The test is easy to use and can be stored at room temperature (2 °C to 30 °C), making it particularly transport-friendly and suitable for flexible use in emergency rooms, clinics or doctors' offices.

With its fast turnaround time of just 12 minutes, the test provides immediate feedback for doctors and patients. This speeds up diagnosis and helps to ensure that patients receive the right treatment quickly, which is crucial in emergencies. The LumiraDx Test Strip SARS-CoV-2 & Flu A/B is therefore an efficient and reliable solution for the rapid and accurate diagnosis of respiratory diseases and optimizes medical care through fast decision making.

LumiraDx Test Strips SARS-CoV-2 & Flu A/B Product details: 

• Rapid microfluidic immunofluorescence test for SARS-CoV-2, Flu A and Flu B
• Results in only 12 minutes, comparable to laboratory values
• Test from a nasal swab sample
• High accuracy: PPA and NPA for all viruses tested
• Can be used with the LumiraDx SARS-CoV-2 & RSV test
• Optimizes patient flow and clinical workflow
• Easy to use and store at room temperature (2 °C to 30 °C)
• Pack contains 24 pieces